Annals of Epidemiology
Volume 11, Issue 7 , Pages 450-457 , October 2001

Hospitalizations for Fractures after Renal Transplantation in the United States

  • Kevin C. Abbott, MD

      Affiliations

    • Nephrology Service, Walter Reed Army Medical Center, Washington, DC USA
    • Corresponding Author InformationAddress reprint requests to: Dr. Kevin C. Abbott, LTC, MC, Director, Dialysis, Nephrology Service, Walter Reed Army Medical Center, Washington, DC 20307-5001. Tel.: (202) 782-6462/6463/6288, Fax: (202) 782-0185.
  • ,
  • Robert J. Oglesby, MD

      Affiliations

    • Rheumatology Service, Walter Reed Army Medical Center, Washington, DC USA
    • Uniformed Services University of the Health Sciences, Bethesda, MD USA
  • ,
  • Iman O. Hypolite

      Affiliations

    • Office of Minority Research Health Coordination, National Institute for Diabetes, Digestive, and Kidney Disease (NIDDK), National Institutes of Health (NIH), Bethesda, MD USA
  • ,
  • Allan D. Kirk, PhD

      Affiliations

    • Organ Transplantation Service, National Institutes of Health, Bethesda, MD USA
  • ,
  • Chia W. Ko, PhD

      Affiliations

    • Epidemiology, Statistics, and Data System Branch, National Institute on Deafness and Other Communication Disorders(NIDCD), NIH, Bethesda, MD USA
  • ,
  • Paul G. Welch, MD

      Affiliations

    • Nephrology Service, Walter Reed Army Medical Center, Washington, DC USA
  • ,
  • Lawrence Y. Agodoa, MD

      Affiliations

    • Uniformed Services University of the Health Sciences, Bethesda, MD USA
    • NIDDK, NIH, Bethesda, MD USA
  • ,
  • William E. Duncan, MD, PhD

      Affiliations

    • Endocrinology Service, Walter Reed Army Medical Center, Washington, DC USA

Received 18 September 2000 ,Revised 8 January 2001 ,Accepted 23 January 2001.

References 

  1. Lindberg JS, Moe SM. Osteoporosis in end-state renal disease. Semin Nephrol. 1999;19:115–122
  2. Pichette V, Bonnardeaux A, Prudhomme L, Gagne M, Cardinal J, Ouimet D. Long-term bone loss in kidney transplant recipients (A cross-sectional and longitudinal study). Am J Kidney Dis. 1996;28:105–114
  3. Coen G. Fracturing osteoporosis after kidney transplantation—What are the options?. Nephrol Dial Transplant. 1996;11:567–569
  4. Epstein S, Shane E, Bilezikian JP. Organ transplantation and osteoporosis. Curr Opin Rheumatol. 1995;7(3):255–261
  5. Nisbeth U, Lindh E, Ljunghall S, Backman U, Fellstrom B. Fracture frequency after kidney transplantation. Transplant Proc. 1994;26(3):1764
  6. Rodino MA, Shane E. Osteoporosis after organ transplantation. Am J Med. 1998;104:459–469
  7. Grotz WH, Mundinger FA, Gugel B, Exner V, Kirste G, Schollmeyer PJ. Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients. Transplantation. 1994;58:912–915
  8. Elmstedt E, Svahn T. Skeletal complications following renal transplantation. Acta Orthop Scand. 1981;52:279–386
  9. Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckert SR, et al. Increased risk of hip fracture among patients with end stage renal disease. Kidney Int. 2000;58:396–399
  10. Cremer J, Struber M, Wagenbreth I, Nischelsky J, Demertzis S, Graeter T, et al. Progression of steroid-associated osteoporosis after heart transplantation. Ann Thorac Surg. 1999;67:130–133
  11. Parker CR, Freemont AJ, Blackwell PJ, Grainge MJ, Hosking DJ. Cross-sectional analysis of renal transplantation osteoporosis. J Bone Miner Res. 1999;14:1943–1951
  12. Almond MK, Kwan JT, Evans K, Cunningham J. Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron. 1994;66:52–57
  13. Cueto-Manzano AM, Konel S, Freemont AJ, Adams JE, Mawer B, Gokal R, et al. Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation. Am J Kidney Dis. 2000;35:227–236
  14. Carlini RG, Rojas E, Weisinger JR, Lopez M, Martinis R, Arminiio A, et al. Bone disease in patients with long-term renal transplantation with normal renal function. Am J Kidney Dis (. 2000;36:160–166
  15. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767–773
  16. Raisz LG. The osteoporosis revolution. Ann Intern Med. 1997;126(6):458–462
  17. Kelepouris N, Harper KD, Gannon F, Kaplan FS, Haddad JG. Severe osteoporosis in men. Ann Intern Med. 1995;123:452–460
  18. Margolis KL, Ensrud KE, Schreiner PJ, Tabor HK. Body size and risk for clinical fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 2000;133(2):123–127
  19. Stethman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS, et al. Risk factors for hip fracture among patients with end stage renal disease. Kidney Int. 2000;58:2200–2205
  20. http://www.usrds.org
  21. www.cdc.gov.nchs
  22. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman AB, Cibrik D, Magee JC, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation. 2000;69:2405–2409
  23. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation. 2000;69:781–789
  24. Fisher L, Vanbelle G. In: Biostatistics. New York: John Wiley & Sons; 1993;p. 771
  25. Kleinbaum DG. Logistic Regression (A Self-Learning Text (Statistics in the Health Sciences)). Berlin: Springer; 1994;
  26. Ojo AO, Kaplan B, Hanson JA, Meier-Kriesche HU, Leichtman AB, Magee JC, et al. Impact of transplant types on long-term mortality in type 1 diabetics with end-stage nephropathy. Transplantation. 2000;69:S270;(Abstract 612)
  27. Gomberg BF, Gruen GS, Smith WR, Spott M. Outcomes in acute orthopedic trauma (A review of 130,506 patients by age). Injury. 1999;30:431–437
  28. Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH. Prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol. 2000;11:1093–1099
  29. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis. 2000;36:1115–1121
  30. Khosla S, Melton LJ, Wermers RA, Crowson CS, O'Fallon WM, Riggs BL. Primary hyperparathyroidism and the risk of fracture (A population-based study). J Bone Miner Res. 1999;14:1700–1707
  31. Carmen Sanchez M, Auxiliadora Bajo M, Selgas R, Mate A, Millan I, Eugenia Martinez M, et al. Parathormone secretion in peritoneal dialysis patients with adynamic bone disease. Am J Kidney Dis. 2000;36(5):953–961
  32. Inaba M, Nishizawa Y, Shioi A, Morii H. Importance of sustained high glucose condition in the development of diabetic osteopenia (Possible involvement of the polyol pathway). Osteoporos Int. 1997;7(Suppl 3):S209–S212
  33. Verhaeghe J, Van Herck E, van Bree R, Moermans K, Bouillon R. Decreased osteoblast activity in spontaneously diabetic rats. In vivo studies on the pathogenesis. Endocrine. 1997;7:165–175
  34. Picton ML, Moore PR, Mawer EB, Houghton D, Freemont AJ, Hutchison AJ, et al. Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int. 2000;58:1440–1449
  35. Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, et al. Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res. 1999;14(3:456–463
  36. Rodino MA, Shane E. Osteoporosis after organ transplantation. Am J Med. 1998;104:459–469
  37. Ensrud KE, Black DM, Pelarmo L, Bauer DC, Barrett-Connor E, Quandt SA, et al. Treatment with alendronate prevents fractures in women at highest risk (Results from the Fracture Intervention Trial). Arch Intern Med. 1997;157:2617–2624
  38. Nevitt MC, Ross PD, Palermo L, Musliner T, Genant HK, Thompson DE. Association of prevalent vertebral fractures, bone Density, and alendronate treatment with incident vertebral fractures (Effect of number and spinal location of fractures). Bone. 1999;25:613–619
  39. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114:919–923
  40. Jehle PM, Jehle DR. Use of corticosteroids in nephrology—Risk and prevention of osteoporosis induction. Nephrol Dial Transplant. 2000;15(5):565–568
  41. Ross PD. Risk factors for osteoporotic fractures. Endocrinol Metab Clin N Am. 1998;27:289–301
  42. Aharonoff GB, Koval KJ, Skovron ML, Zuckerman JD. Hip fractures in the elderly (Predictors of one year mortality). J Orthop Trauma. 1997;11(3):162–165
  43. Cowan DN, DeFraites RF, Gray GC, Goldenbaum MB, Wishik SM. The risk of birth defects among children of Persian Gulf War veterans. N Engl J Med. 1997;336:1650–1656
  44. Cassel CK, Vladeck BC. ICD-9 code for palliative or terminal care. N Engl J Med. 1996;335:1232–1234
  45. Assaf AR, Lapane KL, McKenney JL, Carleton RA. Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease. N Engl J Med. 1993;329:931–935
  46. Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and 6-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320:904–910
  47. Fisher E, Baron J, Malenka D, Barrett J, Bubolz T. Overcoming potential pitfalls in the use of Medicare data for epidemiologic research. Am J Publ Health. 1990;80:1487–1490
  48. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol. 2000;11(Suppl 15):S1–S86

 The opinions expressed are solely those of the authors and do not represent an endorsement by the Department of Defense or the National Institutes of Health. This is a government work. There are no restrictions on its use. Portions of this article were presented at AST 2000 in Chicago, IL, 13-17 May, 2000.

PII: S1047-2797(01)00226-5

Annals of Epidemiology
Volume 11, Issue 7 , Pages 450-457 , October 2001